loading page

Breaktrough drug combination for Congenital Junctional Ectopic Tachycardia: a pediatric case report.
  • Giovanni Di Marco,
  • Angelica De Nigris,
  • Giangiacomo Di Nardo
Giovanni Di Marco
AORN Santobono Pausilipon
Author Profile
Angelica De Nigris
University of Campania Luigi Vanvitelli
Author Profile
Giangiacomo Di Nardo
AORN Santobono Pausilipon
Author Profile

Abstract

Introduction: Congenital Junctional Ectopic Tachycardia (JET) is a rare tachyarrhythmia that remains difficult to manage with suboptimal control in the majority of cases. Methods: Here, we report the successful use of Ivabradine in combination with Flecainide for the therapy of congenital JET resistant to multiple antiarrhythmic agents. Results: This new drug combination was effective in completely suppressing JET . Conclusion: Ivabradine in combination with Flecainide may be considered a new therapeutic strategy of congenital JET with satisfactory efficacy/tolerability ratio in patients resistant to conventional drug combinations.